Cargando…
The future implications and indications of anti-vascular endothelial growth factor therapy in ophthalmic practice
In the last few years anti-vascular endothelial growth factor (VEGF) therapy has changed the paradigm in the treatment of neovascular age-related macular degeneration (ARMD). Besides, its potential use in the treatment of diabetic retinopathy and other possible proliferative vascular disorders has a...
Autores principales: | Hussain, Nazimul, Ghanekar, Yashoda, Kaur, Inderjeet |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2635990/ https://www.ncbi.nlm.nih.gov/pubmed/17951902 |
Ejemplares similares
-
The economic implications of the use of anti-vascular endothelial growth factor drugs in age-related macular degeneration
por: Azad, Rajvardhan, et al.
Publicado: (2007) -
Introduction, mechanism of action and rationale for anti-vascular endothelial growth factor drugs in age-related macular degeneration
por: Kim, Ramasamy
Publicado: (2007) -
A comparative debate on the various anti-vascular endothelial growth factor drugs: Pegaptanib sodium (Macugen), ranibizumab (Lucentis) and bevacizumab (Avastin)
por: Nagpal, Manish, et al.
Publicado: (2007) -
Role of imaging in the management of neuro-ophthalmic disorders
por: Gandhi, Rashmin Anilkumar, et al.
Publicado: (2011) -
Innovations in glaucoma surgery from Dr. Rajendra Prasad Centre for Ophthalmic Sciences
por: Dada, Tanuj, et al.
Publicado: (2017)